FSRT vs. SRS in Brain Metastases—Differences in Local Control and Radiation Necrosis—A Volumetric Study

FSRT vs. SRS in Brain Metastases—Differences in Local Control and Radiation Necrosis—A Volumetric Study

Background: While the role of stereotactic radiotherapy for brain metastases is increasing, evidence on the comparative efficacy and safety of fractionated stereotactic radiotherapy (FSRT) and single-session radiosurgery (SRS) is scarce.Methods: Longitudinal volumetric analysis was performed in a co...

Full description

Bibliographic Details
Main Authors:	Florian Putz, Thomas Weissmann, Dominik Oft, Manuel Alexander Schmidt, Johannes Roesch, Hadi Siavooshhaghighi, Irina Filimonova, Charlotte Schmitter, Veit Mengling, Christoph Bert, Benjamin Frey, Sebastian Lettmaier, Luitpold Valentin Distel, Sabine Semrau, Rainer Fietkau
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Oncology
Subjects:	brain metastases stereotactic radiotherapy (SRT) stereotactic radiosurgery (SRS) fractionated stereotactic radiotherapy volumetric analysis segmentation
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.559193/full

Similar Items

The Expanding Role of Radiosurgery for Brain Metastases
by: Mark O’Beirn, et al.
Published: (2018-08-01)

Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
by: Dominik Oft, et al.
Published: (2021-01-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
by: Jakob Liermann, et al.
Published: (2020-10-01)

Improving the therapeutic ratio of stereotactic radiosurgery and radiotherapy
by: Andisheh, Bahram
Published: (2012)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases
by: Nitesh Rana, et al.
Published: (2017-11-01)

Indications, feasibility, safety, and efficacy of CyberKnife radiotherapy for the treatment of olfactory groove meningiomas: a single institutional retrospective series
by: Jianmin Liu, et al.
Published: (2020-03-01)

Sector Irradiation vs. Whole Brain Irradiation After Resection of Singular Brain Metastasis—A Prospective Randomized Monocentric Trial
by: Johannes Kerschbaumer, et al.
Published: (2020-11-01)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney Brandon M, et al.
Published: (2012-05-01)

STEREOTACTIC RADIOTHERAPY AND RADIOSURGERY IN THE TREATMENT OF PATIENTS WITH BRAIN PILOID ASTROCYTOMAS OF DEEP LOCATION
by: Yu. Yu. Trunin, et al.
Published: (2015-04-01)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
by: Conti Alfredo, et al.
Published: (2019-11-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Are brain metastases curable? Case report and a brief review of the literature
by: Juan Enrique Gutierrez Valencia, et al.
Published: (2019-01-01)

The RABBIT risk-based approach to clinical implementation of new technology: SRS as a case study
by: Anna Ralston, et al.
Published: (2020-06-01)

Radiotherapy management of brain metastases using conventional linear accelerator
by: Marcel Matzenauer, et al.
Published: (2016-09-01)

Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience
by: Shaakir eHasan, et al.
Published: (2015-05-01)

Simultaneous optimization of radiation-imaging coincidence for a multi-energy linac
by: Cory Knill, et al.
Published: (2021-01-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2021-12-01)

Current status and recent advances in resection cavity irradiation of brain metastases
by: Giuseppe Minniti, et al.
Published: (2021-04-01)

Frameless Image-Guided Radiosurgery for Multiple Brain Metastasis Using VMAT: A Review and an Institutional Experience
by: Samir Abdallah Hanna, et al.
Published: (2019-08-01)

Stereotactic body radiation therapy for clinically localized prostate cancer
by: N. A. Vorobyov, et al.
Published: (2018-07-01)

Enlarged piloid astrocytoma of the midbrain: recurrence or pseudoprogression? A clinical case
by: Yu. Yu. Trunin, et al.
Published: (2016-03-01)

An Overview of Managements in Meningiomas
by: Lianhua Zhao, et al.
Published: (2020-08-01)

Corrigendum: An Overview of Managements in Meningiomas
by: Lianhua Zhao, et al.
Published: (2020-09-01)

Role of Radiotherapy in Metastatic Non-small Cell Lung Cancer (NSCLC)
by: Sergio L. Faria
Published: (2014-10-01)

Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer
by: Robert eMeier
Published: (2015-04-01)

Malignant melanoma and radiotherapy: Past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future management
by: Pooya eJahanshahi, et al.
Published: (2012-11-01)

Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-small Cell Lung Cancer
by: Hongqi Li, et al.
Published: (2018-12-01)

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)
by: David Krug, et al.
Published: (2021-05-01)

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases—Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept
by: Rami A. El Shafie, et al.
Published: (2019-03-01)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
by: Rami A. El Shafie, et al.
Published: (2020-05-01)

Stereotactic Radiotherapy for Parasagittal and Parafalcine Meningiomas: Patient Selection and Special Considerations
by: Pinzi V, et al.
Published: (2019-11-01)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
by: Carsten Herskind, et al.
Published: (2017-07-01)

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases
by: Rami A. El Shafie, et al.
Published: (2020-05-01)

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery
by: Mikhail Chetvertkov, et al.
Published: (2020-11-01)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
by: Yining Gong, et al.
Published: (2019-10-01)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
by: Claessens, M., et al.
Published: (2022)

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
by: Mathew AS, et al.
Published: (2021-06-01)

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
by: A. van Linge, et al.
Published: (2018-12-01)

Cannot write session to /tmp/vufind_sessions/sess_2p7drtu804baqeum2qqee7fraa